Literature DB >> 9504768

Polymerase chain reaction for detection of JC virus DNA in cerebrospinal fluid: a quality control study. European Union Concerted Action on Viral Meningitis and Encephalitis.

T Weber1, P E Klapper, G M Cleator, M Bodemer, W Lüke, W Knowles, P Cinque, A M Van Loon, M Grandien, A L Hammarin, M Ciardi, G Bogdanovic.   

Abstract

The sensitivity and specificity of PCR of CSF for the diagnosis of progressive multifocal leuko encephalopathy is estimated at 75 and 98.5%, respectively. However, inter-laboratory and inter-technique variations have been shown to produce wide variations. A 10-fold dilution series of JC virus in cerebrospinal fluid was prepared and circulated for 'blind' evaluation in laboratories participating in a European Union Concerted Action on Virus Meningitis and Encephalitis. Six of seven laboratories returned results with sensitivity of between 10 and 1 JCV DNA copy equivalents per 10 microl of CSF, one laboratory detected 10(5) copies per 10 microl of CSF. These results demonstrate the feasibility of using virus diluted in CSF for comparison of PCR techniques, and that the range of sensitivity of JCV PCR in proficient laboratories is between 10 and 1 copy equivalents per 10 microl of CSF.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9504768     DOI: 10.1016/s0166-0934(97)00152-3

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  10 in total

1.  Progressive Multifocal Leukoencephalopathy.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-07       Impact factor: 3.598

2.  Amyloid and tau cerebrospinal fluid biomarkers in HIV infection.

Authors:  Magnus Gisslén; Jan Krut; Ulf Andreasson; Kaj Blennow; Paola Cinque; Bruce J Brew; Serena Spudich; Lars Hagberg; Lars Rosengren; Richard W Price; Henrik Zetterberg
Journal:  BMC Neurol       Date:  2009-12-22       Impact factor: 2.474

Review 3.  The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: defining a consensus terminology.

Authors:  Paola Cinque; Igor J Koralnik; David B Clifford
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

Review 4.  Natalizumab and progressive multifocal leucoencephalopathy.

Authors:  J R Berger
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

Review 5.  Molecular methods for diagnosis of viral encephalitis.

Authors:  Roberta L Debiasi; Kenneth L Tyler
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

6.  Focal Brain Lesions in People with HIV.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-05       Impact factor: 3.972

7.  First external quality assurance program for bloodstream Real-Time PCR monitoring of treatment response in clinical trials of Chagas disease.

Authors:  Juan C Ramírez; Rudy Parrado; Elena Sulleiro; Anabelle de la Barra; Marcelo Rodríguez; Sandro Villarroel; Lucía Irazu; Cristina Alonso-Vega; Fabiana Alves; María A Curto; Lineth García; Lourdes Ortiz; Faustino Torrico; Joaquim Gascón; Laurence Flevaud; Israel Molina; Isabela Ribeiro; Alejandro G Schijman
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

Review 8.  Molecular analysis of cerebrospinal fluid in viral diseases of the central nervous system.

Authors:  Paola Cinque; Simona Bossolasco; Ake Lundkvist
Journal:  J Clin Virol       Date:  2003-01       Impact factor: 3.168

9.  Quantification of human and animal viruses to differentiate the origin of the fecal contamination present in environmental samples.

Authors:  Sílvia Bofill-Mas; Marta Rusiñol; Xavier Fernandez-Cassi; Anna Carratalà; Ayalkibet Hundesa; Rosina Girones
Journal:  Biomed Res Int       Date:  2013-05-15       Impact factor: 3.411

10.  CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration.

Authors:  Sahra Abdulle; Asa Mellgren; Bruce J Brew; Paola Cinque; Lars Hagberg; Richard W Price; Lars Rosengren; Magnus Gisslén
Journal:  J Neurol       Date:  2007-04-10       Impact factor: 6.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.